Cas No.: 1193347-53-3
PRODUCT INFORMATION
Description
Cyclo(Arg-Ala-Asp-D-Tyr-Lys) (c(RADyK)) serves as a critical negative control peptide for c(RGDyK) studies. The substitution of Gly with Ala at position 2 (RGD→RAD) disrupts the native αVβ3 integrin binding capability. This structural modification enables researchers to differentiate RGD-mediated biological effects from nonspecific interactions in integrin-targeted in vitro experiments.
Molecular Weight
633.70
Purity
> 95%
Formula
C₂₈H₄₃N₉O₈
Product Type
Targeting Peptide
Sequence
Cyclo[Ala-D-Asp-D-Tyr-Lys-Arg]
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Somatostatin-28 (1-14) Targeting Peptide (CAT#: OLY-1025-YS-60)
- Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle) Targeting Peptide (CAT#: OLY-1025-YS-62)
- Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA Targeting Peptide (CAT#: OLY-1025-YS-51)
- Octreotide Targeting Peptide (CAT#: OLY-1025-YS-3)
- NBD-LLLLpY Targeting Peptide (CAT#: OLY-1025-YS-50)
- LinTT1 Targeting Peptide (CAT#: OLY-1025-YS-24)
- CSTSMLKAC (disulfide) Targeting Peptide (CAT#: OLY-1025-YS-55)
- Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA Targeting Peptide (CAT#: OLY-1025-YS-68)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.